The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 99.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 4,952 shares of the medical device company's stock after selling 474,257 shares during the period. ExodusPoint Capital Management LP's holdings in Cooper Companies were worth $455,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. HighTower Advisors LLC boosted its position in shares of Cooper Companies by 11.7% in the third quarter. HighTower Advisors LLC now owns 20,506 shares of the medical device company's stock worth $2,261,000 after acquiring an additional 2,155 shares during the last quarter. MML Investors Services LLC raised its stake in Cooper Companies by 1.6% during the third quarter. MML Investors Services LLC now owns 17,787 shares of the medical device company's stock worth $1,963,000 after purchasing an additional 280 shares during the period. Barclays PLC boosted its holdings in shares of Cooper Companies by 0.7% in the 3rd quarter. Barclays PLC now owns 462,947 shares of the medical device company's stock valued at $51,082,000 after purchasing an additional 3,070 shares during the last quarter. Coldstream Capital Management Inc. acquired a new position in shares of Cooper Companies in the 3rd quarter valued at $208,000. Finally, Toronto Dominion Bank grew its stake in shares of Cooper Companies by 15.4% during the 3rd quarter. Toronto Dominion Bank now owns 66,772 shares of the medical device company's stock valued at $7,368,000 after buying an additional 8,900 shares during the period. Hedge funds and other institutional investors own 24.39% of the company's stock.

Remove Ads

Cooper Companies Stock Performance

Shares of COO stock traded down $0.96 during trading hours on Tuesday, reaching $77.80. The stock had a trading volume of 1,386,329 shares, compared to its average volume of 1,399,687. The firm has a market capitalization of $15.56 billion, a PE ratio of 39.90, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The firm has a 50-day simple moving average of $83.93 and a 200-day simple moving average of $94.19. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. Citigroup cut their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Robert W. Baird reduced their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a report on Thursday, March 13th. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Friday, March 7th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.